Thanks, we’ve received your application.

Our team will review your application to see if your skills and experience are a good fit for the position – in the meantime, learn about the latest clinical evidence supporting the CathWorks FFRangio System.

FFRangio Validation Study

The FFRangio Validation study evaluated 203 lesions in 184 patients and showed that there is high concordance between FFRangio and invasive FFR, including a diagnostic accuracy of 93%.

Read More arrow_forward

FAST-FFR Pivotal Trial

The FAST-FFR pivotal trial was a prospective multicenter, international trial designed to determine the accuracy of FFRangio in clinical practice compared to traditional wire-based FFR. The trial included 301 patients and 319 vessels at 10 clinical sites.

Read More arrow_forward

FFRangio in Dual/Triple Vessel Disease

This prospective clinical study conducted at Gifu Heart Centre, Japan—evaluated the diagnostic performance of FFRangio in 50 patients with dual or triple vessel CAD compared to wire-based FFR.

Read More arrow_forward

FFRangio Pooled Analysis from 5 Prospective Cohort Studies

This lesion-level pooled data analysis of 588 patients and 700 lesions represents the “largest and most diverse cohort of any single angiogram-based FFR technology reported.”

Read More arrow_forward
expand_lessBack to top of page

We use cookies to enhance your experience. By continuing to visit this site, you agree to our use of cookies. Terms and Conditions